帕金森病丘脑底核深部脑刺激后腹侧前纹状体多巴胺转运体增加与运动恢复相关
该研究对10例接受双侧丘脑底核深部脑刺激的帕金森病患者,在术前及术后1年进行[11C]CFT PET扫描,分析纹状体多巴胺转运体结合与UPDRS评分变化的相关性。结果显示术后腹侧前纹状体[11C]CFT结合增加,且其增加百分比与UPDRS-II和UPDRS-III评分下降百分比显著相关,提示丘脑底核深部脑刺激可能对多巴胺能神经末梢有神经调控效应。
要点
- 术后1年对侧后背部壳核[11C]CFT摄取显著减少,而对侧腹前部壳核及同侧腹侧尾状核摄取增加(p < 0.05)。
- 同侧腹前部壳核[11C]CFT结合增加百分比与UPDRS-II评分下降百分比显著相关(p < 0.05)。
- 同侧腹前部壳核、腹侧尾状核及伏隔核[11C]CFT结合增加百分比与UPDRS-III评分下降百分比显著相关(p < 0.05)。
核心结论
- 丘脑底核深部脑刺激增加腹侧前纹状体多巴胺转运体水平,该变化与运动恢复相关,可能提示丘脑底核深部脑刺激对帕金森病患者多巴胺能神经末梢的神经调控效应。
- 术前前部纹状体多巴胺转运体水平可能预测丘脑底核深部脑刺激对运动恢复的储备能力。
研究设计与样本
- 研究纳入10例接受双侧丘脑底核深部脑刺激的帕金森病患者,在术前及术后1年分别进行[11C]CFT PET扫描,分析[11C]CFT结合与术前及术后关期UPDRS评分的相关性。
主要发现
- 术后1年,与帕金森症状优势侧对侧的后背部壳核[11C]CFT摄取显著减少,而对侧腹前部壳核及同侧腹侧尾状核摄取增加(p < 0.05)。
- [11C]CFT结合增加百分比与双侧腹前部壳核、同侧腹侧尾状核、对侧前背部壳核、对侧后腹部壳核及对侧伏隔核的术前结合水平呈负相关。
- UPDRS-II评分下降百分比与同侧腹前部壳核[11C]CFT结合增加百分比显著相关(p < 0.05)。
- UPDRS-III评分下降百分比与同侧腹前部壳核、腹侧尾状核及伏隔核[11C]CFT结合增加百分比显著相关(p < 0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson's disease is effective; however, its mechanism is unclear. To investigate the degree of neuronal terminal survival after STN-DBS, the authors examined the striatal dopamine transporter levels before and after treatment in association with clinical improvement using PET with [11C]2β-carbomethoxy-3β-(4-fluorophenyl)tropane ([11C]CFT). METHODS: Ten patients with Parkinson's disease who had undergone bilateral STN-DBS were scanned twice with [11C]CFT PET just before and 1 year after surgery. Correlation analysis was conducted between [11C]CFT binding and off-period Unified Parkinson's Disease Rating Scale (UPDRS) scores assessed preoperatively and postoperatively. RESULTS: [11C]CFT uptake reduced significantly in the posterodorsal putamen contralateral to the parkinsonism-dominant side after 1 year; however, an increase was noted in the contralateral anteroventral putamen and ipsilateral ventral caudate postoperatively (p < 0.05). The percentage increase in [11C]CFT binding was inversely correlated with the preoperative binding level in the bilateral anteroventral putamen, ipsilateral ventral caudate, contralateral anterodorsal putamen, contralateral posteroventral putamen, and contralateral nucleus accumbens. The percentage reduction in UPDRS-II score was significantly correlated with the percentage increase in [11C]CFT binding in the ipsilateral anteroventral putamen (p < 0.05). The percentage reduction in UPDRS-III score was significantly correlated with the percentage increase in [11C]CFT binding in the ipsilateral anteroventral putamen, ventral caudate, and nucleus accumbens (p < 0.05). CONCLUSIONS: STN-DBS increases dopamine transporter levels in the anteroventral striatum, which is correlated with the motor recovery and possibly suggests the neuromodulatory effect of STN-DBS on dopaminergic terminals in Parkinson's disease patients. A preoperative level of anterior striatal dopamine transporter may predict reserve capacity of STN-DBS on motor recovery.
引用
- Nozaki T, Sugiyama K, Asakawa T, et al. Increased anteroventral striatal dopamine transporter and motor recovery after subthalamic deep brain stimulation in Parkinson's disease. J Neurosurg. 2021. PMID: 34972089. doi:10.3171/2021.10.JNS211364
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。